688137 近岸蛋白
已收盘 09-14 15:00:00
资讯
新帖
简况
每周股票复盘：近岸蛋白（688137）因股价涨幅达15%登龙虎榜
证券之星 · 09-13 01:59
每周股票复盘：近岸蛋白（688137）因股价涨幅达15%登龙虎榜
9月11日近岸蛋白跌8.14%，华商恒鑫回报混合A基金重仓该股
证券之星 · 09-11
9月11日近岸蛋白跌8.14%，华商恒鑫回报混合A基金重仓该股
9月8日近岸蛋白（688137）龙虎榜数据：机构净卖出754.97万元
证券之星 · 09-08
9月8日近岸蛋白（688137）龙虎榜数据：机构净卖出754.97万元
9月8日近岸蛋白涨15.33%，华商恒鑫回报混合A基金重仓该股
证券之星 · 09-08
9月8日近岸蛋白涨15.33%，华商恒鑫回报混合A基金重仓该股
9月3日近岸蛋白跌12.31%，华商恒鑫回报混合A基金重仓该股
证券之星 · 09-03
9月3日近岸蛋白跌12.31%，华商恒鑫回报混合A基金重仓该股
破发股近岸蛋白跌12.31% 上市募18.6亿国联民生保荐
中金财经 · 09-03
破发股近岸蛋白跌12.31% 上市募18.6亿国联民生保荐
9月1日近岸蛋白涨5.41%，华商恒鑫回报混合A基金重仓该股
证券之星 · 09-01
9月1日近岸蛋白涨5.41%，华商恒鑫回报混合A基金重仓该股
股市必读：近岸蛋白中报 - 第二季度单季净利润同比下降49.82%
证券之星 · 08-31
股市必读：近岸蛋白中报 - 第二季度单季净利润同比下降49.82%
每周股票复盘：近岸蛋白（688137）股东户数降5.49%，中报营收增8.88%
证券之星 · 08-30
每周股票复盘：近岸蛋白（688137）股东户数降5.49%，中报营收增8.88%
近岸蛋白（688137）披露2026年半年度计提资产减值准备的公告，8月28日股价下跌11.29%
证券之星 · 08-28
近岸蛋白（688137）披露2026年半年度计提资产减值准备的公告，8月28日股价下跌11.29%
近岸蛋白(688137)6月30日股东户数0.64万户，较上期减少5.49%
证券之星 · 08-28
近岸蛋白(688137)6月30日股东户数0.64万户，较上期减少5.49%
破发股近岸蛋白跌11.29% 上市募18.6亿国联民生保荐
中金财经 · 08-28
破发股近岸蛋白跌11.29% 上市募18.6亿国联民生保荐
图解近岸蛋白中报：第二季度单季净利润同比下降49.82%
证券之星 · 08-28
图解近岸蛋白中报：第二季度单季净利润同比下降49.82%
股市必读：近岸蛋白新发布《国联民生证券承销保荐有限公司关于苏州近岸蛋白质科技股份有限公司部分募集资金投资项目延期的专项核查意见》
证券之星 · 08-28
股市必读：近岸蛋白新发布《国联民生证券承销保荐有限公司关于苏州近岸蛋白质科技股份有限公司部分募集资金投资项目延期的专项核查意见》
近岸蛋白(688137.SH)发布半年度业绩，归母净亏损2920.45万元
智通财经 · 08-28
近岸蛋白(688137.SH)发布半年度业绩，归母净亏损2920.45万元
8月25日近岸蛋白涨10.64%，华商恒鑫回报混合A基金重仓该股
证券之星 · 08-25
8月25日近岸蛋白涨10.64%，华商恒鑫回报混合A基金重仓该股
破发股近岸蛋白跌6.79% 上市募18.6亿国联民生保荐
中金财经 · 08-24
破发股近岸蛋白跌6.79% 上市募18.6亿国联民生保荐
8月24日近岸蛋白跌6.79%，华商恒鑫回报混合A基金重仓该股
证券之星 · 08-24
8月24日近岸蛋白跌6.79%，华商恒鑫回报混合A基金重仓该股
股市必读：近岸蛋白（688137）登8月21日交易所龙虎榜
证券之星 · 08-24
股市必读：近岸蛋白（688137）登8月21日交易所龙虎榜
每周股票复盘：近岸蛋白（688137）连续三日涨逾30%
证券之星 · 08-23
每周股票复盘：近岸蛋白（688137）连续三日涨逾30%
加载更多
公司概况
公司名称：
苏州近岸蛋白质科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-09-29
主营业务：
苏州近岸蛋白质科技股份有限公司的主营业务是靶点及因子类蛋白、重组抗体、酶及试剂的研发、生产、销售并提供相关技术服务。公司的主要产品是靶点及因子类蛋白、重组抗体、酶及试剂。
发行价格：
106.19
{"stockData":{"symbol":"688137","market":"SH","secType":"STK","nameCN":"近岸蛋白","latestPrice":76.8,"timestamp":1789369200000,"preClose":64,"halted":0,"volume":9108489,"delay":0,"changeRate":0.2,"floatShares":69917500,"shares":69917500,"eps":-1.1838,"marketStatus":"已收盘","change":12.8,"latestTime":"09-14 15:00:00","open":65.33,"high":76.8,"low":62.51,"amount":648000000,"amplitude":0.2233,"askPrice":0,"askSize":0,"bidPrice":76.8,"bidSize":6856,"shortable":0,"etf":0,"ttmEps":-1.1838,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"adjPreClose":64,"symbolType":"stock_kcb","openAndCloseTimeList":[[1789349400000,1789356600000],[1789362000000,1789369200000]],"highLimit":70.4,"lowLimit":57.6,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":69917453,"isCdr":false,"pbRate":2.69,"roa":"--","roe":"--","epsLYR":-1.11,"committee":0,"marketValue":5370000000,"turnoverRate":0.1303,"status":0,"afterMarket":{"amount":0,"volume":0,"close":76.8,"buyVolume":22885,"sellVolume":0,"time":1789371237746,"indexStatus":"已收盘 09-14 15:30:00","preClose":64},"floatMarketCap":5370000000},"requestUrl":"/m/hq/s/688137","defaultTab":"news","newsList":[{"id":"2667076515","title":"每周股票复盘：近岸蛋白（688137）因股价涨幅达15%登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2667076515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667076515?lang=zh_cn&edition=full","pubTime":"2026-09-13 01:59","pubTimestamp":1789235949,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，近岸蛋白报收于64.0元，较上周的62.15元上涨2.98%。本周，近岸蛋白9月9日盘中最高价报75.05元。9月8日盘中最低价报59.5元。近岸蛋白当前最新总市值44.75亿元，在生物制品板块市值排名41/51，在两市A股市值排名3420/5218。本周关注点交易信息汇总：近岸蛋白因日收盘价格涨幅达到15%登上龙虎榜。此次是近5个交易日内第1次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666547922","title":"9月11日近岸蛋白跌8.14%，华商恒鑫回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666547922","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666547922?lang=zh_cn&edition=full","pubTime":"2026-09-11 16:34","pubTimestamp":1789115665,"startTime":"0","endTime":"0","summary":"证券之星消息，9月11日近岸蛋白跌8.14%，收盘报64.0元，换手率7.9%，成交量5.52万手，成交额3.67亿元。重仓近岸蛋白的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华商基金的华商恒鑫回报混合A。华商恒鑫回报混合A目前规模为0.36亿元，最新净值1.2583，较上一交易日下跌0.25%，近一年上涨23.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100035601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329457","title":"9月8日近岸蛋白（688137）龙虎榜数据：机构净卖出754.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329457","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665329457?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:52","pubTimestamp":1788861179,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年9月8日公布的交易公开信息显示，近岸蛋白因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年9月8日收盘，近岸蛋白报收于71.01元，上涨15.33%，换手率13.1%，成交量9.16万手，成交额6.0亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出754.97万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800027747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665120325","title":"9月8日近岸蛋白涨15.33%，华商恒鑫回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665120325","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665120325?lang=zh_cn&edition=full","pubTime":"2026-09-08 16:39","pubTimestamp":1788856747,"startTime":"0","endTime":"0","summary":"证券之星消息，9月8日近岸蛋白涨15.33%，收盘报71.01元，换手率13.1%，成交量9.16万手，成交额6.0亿元。重仓近岸蛋白的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华商基金的华商恒鑫回报混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800026114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664515820","title":"9月3日近岸蛋白跌12.31%，华商恒鑫回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664515820","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664515820?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:37","pubTimestamp":1788424661,"startTime":"0","endTime":"0","summary":"证券之星消息，9月3日近岸蛋白跌12.31%，收盘报63.77元，换手率7.88%，成交量5.51万手，成交额3.63亿元。重仓近岸蛋白的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华商基金的华商恒鑫回报混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300030064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827590","title":"破发股近岸蛋白跌12.31% 上市募18.6亿国联民生保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827590","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664827590?lang=zh_cn&edition=full","pubTime":"2026-09-03 15:56","pubTimestamp":1788422162,"startTime":"0","endTime":"0","summary":"中国经济网北京9月3日讯 近岸蛋白 今日收报63.77元，跌幅12.31%。该股目前处于破发状态。 近岸蛋白于2022年9月29日在上交所科创板上市，发行价格为106.19元/股，发行股票数量为1,754.3860万股，保荐人为民生证券股份有限公司，保荐代表人为王璐、黄立超。 近岸蛋白首次公开发行股票募集资金总额为186,298.25万元，扣除发行费用后募集资金净额为174,219.58万元。 近岸蛋白首次公开发行股票的发行费用总额为12,078.67万元，其中，承销保荐费用9,842.17万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260903/32358971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688137","BK0276","BK1147","IPOS","BK0216","601456","BK1564","01456"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664834709","title":"9月1日近岸蛋白涨5.41%，华商恒鑫回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664834709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664834709?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:36","pubTimestamp":1788251818,"startTime":"0","endTime":"0","summary":"证券之星消息，9月1日近岸蛋白涨5.41%，收盘报72.49元，换手率8.17%，成交量5.71万手，成交额4.08亿元。重仓近岸蛋白的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华商基金的华商恒鑫回报混合A。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100028484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663042467","title":"股市必读：近岸蛋白中报 - 第二季度单季净利润同比下降49.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663042467","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663042467?lang=zh_cn&edition=full","pubTime":"2026-08-31 02:34","pubTimestamp":1788114851,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年第二季度归母净利润为-1860.01万元，同比下降49.82%。业绩披露要点财务报告2026年中报显示，上半年度公司主营收入7849.61万元，同比上升8.88%；归母净利润-2920.45万元，同比下降20.56%；扣非净利润-2977.57万元，同比下降11.58%；其中第二季度单季度主营收入4124.94万元，同比上升6.73%；单季度归母净利润-1860.01万元，同比下降49.82%；单季度扣非净利润-1917.26万元，同比下降34.26%；负债率6.56%，财务费用-1011.86万元，毛利率68.75%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100000788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663010642","title":"每周股票复盘：近岸蛋白（688137）股东户数降5.49%，中报营收增8.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010642","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663010642?lang=zh_cn&edition=full","pubTime":"2026-08-30 02:37","pubTimestamp":1788028629,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，近岸蛋白报收于73.32元，较上周的80.99元下跌9.47%。本周关注点股本股东变化：股东户数较3月31日减少5.49%，户均持股升至1.1万股。业绩披露要点：2026年上半年主营收入7849.61万元，同比上升8.88%。截至2026年6月30日，累计使用募集资金65,465.35万元，期末余额45,397.68万元。实施股份回购，累计回购662,323股，支付金额2,245.28万元，并注销257,986股。公司已履行董事会审批程序，保荐机构对该事项无异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000000890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662699520","title":"近岸蛋白（688137）披露2026年半年度计提资产减值准备的公告，8月28日股价下跌11.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662699520","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662699520?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:00","pubTimestamp":1787911248,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，近岸蛋白报收于73.32元，较前一交易日下跌11.29%，最新总市值为51.26亿元。该股当日开盘78.0元，最高79.88元，最低73.15元，成交额达4.89亿元，换手率为9.13%。公司于近日披露《关于2026年半年度计提资产减值准备的公告》。公告显示，苏州近岸蛋白质科技股份有限公司根据《企业会计准则》和公司会计政策，对截至2026年6月30日的资产进行减值测试，2026年半年度计提各项资产减值准备合计1,188.30万元。上述计提减少公司合并报表利润总额1,188.30万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800042064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706686","title":"近岸蛋白(688137)6月30日股东户数0.64万户，较上期减少5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706686","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662706686?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:41","pubTimestamp":1787910065,"startTime":"0","endTime":"0","summary":"证券之星消息，近日近岸蛋白披露，截至2026年6月30日公司股东户数为6364.0户，较3月31日减少370.0户，减幅为5.49%。在生物制品行业个股中，近岸蛋白股东户数低于行业平均水平，截至6月30日，生物制品行业平均股东户数为3.54万户。从股价来看，2026年3月31日至2026年6月30日，近岸蛋白区间跌幅为11.07%，在此期间股东户数减少370.0户，减幅为5.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800040713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662050799","title":"破发股近岸蛋白跌11.29% 上市募18.6亿国联民生保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2662050799","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662050799?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:23","pubTimestamp":1787905382,"startTime":"0","endTime":"0","summary":"中国经济网北京8月28日讯 近岸蛋白 今日收报73.32元，跌幅11.29%。该股目前处于破发状态。 近岸蛋白于2022年9月29日在上交所科创板上市，发行价格为106.19元/股，发行股票数量为1,754.3860万股，保荐人为民生证券股份有限公司，保荐代表人为王璐、黄立超。 近岸蛋白首次公开发行股票募集资金总额为186,298.25万元，扣除发行费用后募集资金净额为174,219.58万元。 近岸蛋白首次公开发行股票的发行费用总额为12,078.67万元，其中，承销保荐费用9,842.17万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260828/32351803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1564","IPOS","01456","601456","BK1147","BK0276","688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662833087","title":"图解近岸蛋白中报：第二季度单季净利润同比下降49.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662833087","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662833087?lang=zh_cn&edition=full","pubTime":"2026-08-28 02:02","pubTimestamp":1787853739,"startTime":"0","endTime":"0","summary":"证券之星消息，近岸蛋白2026年中报显示，上半年度公司主营收入7849.61万元，同比上升8.88%；归母净利润-2920.45万元，同比下降20.56%；扣非净利润-2977.57万元，同比下降11.58%；其中2026年第二季度，公司单季度主营收入4124.94万元，同比上升6.73%；单季度归母净利润-1860.01万元，同比下降49.82%；单季度扣非净利润-1917.26万元，同比下降34.26%；负债率6.56%，财务费用-1011.86万元，毛利率68.75%。财报数据概要请见下图:本文数据来源于近岸蛋白2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800005519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208264","title":"股市必读：近岸蛋白新发布《国联民生证券承销保荐有限公司关于苏州近岸蛋白质科技股份有限公司部分募集资金投资项目延期的专项核查意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208264","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662208264?lang=zh_cn&edition=full","pubTime":"2026-08-28 01:23","pubTimestamp":1787851392,"startTime":"0","endTime":"0","summary":"公司公告汇总国联民生证券承销保荐有限公司关于苏州近岸蛋白质科技股份有限公司部分募集资金投资项目延期的专项核查意见苏州近岸蛋白质科技股份有限公司因项目实际建设进度及行业环境等因素，决定将募投项目“诊断核心原料及创新诊断试剂产业化项目”和“研发中心建设项目”的达到预定可使用状态日期由2026年9月延期至2027年9月。公司已召开董事会审议通过该事项，保荐机构对该延期事项无异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800003874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1564","688137","161027","BK0216","BK1147","601456","01456","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662846050","title":"近岸蛋白(688137.SH)发布半年度业绩，归母净亏损2920.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662846050","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662846050?lang=zh_cn&edition=full","pubTime":"2026-08-28 00:33","pubTimestamp":1787848419,"startTime":"0","endTime":"0","summary":"智通财经APP讯，近岸蛋白(688137.SH)披露2026年半年度报告，报告期公司实现营业收入7849.61万元，同比增长8.88%;归属于上市公司股东的净利润亏损2920.45万元;归属于上市公司股东的扣除非经常性损益的净利润亏损2977.57万元;基本每股收益-0.42元。业绩变动主要系报告期内公司加大技术研发和营销投入以及递延所得税费用增加所致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662822967","title":"8月25日近岸蛋白涨10.64%，华商恒鑫回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662822967","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662822967?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:36","pubTimestamp":1787646992,"startTime":"0","endTime":"0","summary":"证券之星消息，8月25日近岸蛋白涨10.64%创60日新高，收盘报83.52元，换手率10.84%，成交量7.58万手，成交额6.1亿元。重仓近岸蛋白的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华商基金的华商恒鑫回报混合A。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500033731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661622437","title":"破发股近岸蛋白跌6.79% 上市募18.6亿国联民生保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2661622437","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661622437?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:40","pubTimestamp":1787560805,"startTime":"0","endTime":"0","summary":"中国经济网北京8月24日讯 近岸蛋白 今日收报75.49元，跌幅6.79%。该股目前处于破发状态。 近岸蛋白于2022年9月29日在上交所科创板上市，发行价格为106.19元/股，发行股票数量为1,754.3860万股，保荐人为民生证券股份有限公司，保荐代表人为王璐、黄立超。 近岸蛋白首次公开发行股票募集资金总额为186,298.25万元，扣除发行费用后募集资金净额为174,219.58万元。 近岸蛋白首次公开发行股票的发行费用总额为12,078.67万元，其中，承销保荐费用9,842.17万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260824/32344878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","IPOS","BK1564","BK1147","601456","BK0276","01456","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661265221","title":"8月24日近岸蛋白跌6.79%，华商恒鑫回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661265221","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661265221?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:33","pubTimestamp":1787560400,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日近岸蛋白跌6.79%创60日新高，收盘报75.49元，换手率10.52%，成交量7.35万手，成交额5.65亿元。重仓近岸蛋白的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华商基金的华商恒鑫回报混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400021848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220243","title":"股市必读：近岸蛋白（688137）登8月21日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661220243?lang=zh_cn&edition=full","pubTime":"2026-08-24 01:05","pubTimestamp":1787504712,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，近岸蛋白报收于80.99元，上涨20.0%，已连续涨停2天，换手率15.12%，成交量10.57万手，成交额7.95亿元。公司公告汇总：近岸蛋白股票于8月19日至21日连续3个交易日收盘价涨幅偏离值累计超30%，且8月6日至21日10个交易日内发生3次异常波动，构成严重异常波动；公司确认无应披露未披露重大信息，2026年上半年预计净亏损2950万元至2650万元，较去年同期增亏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400000785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661211931","title":"每周股票复盘：近岸蛋白（688137）连续三日涨逾30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661211931","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661211931?lang=zh_cn&edition=full","pubTime":"2026-08-23 01:47","pubTimestamp":1787420831,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，近岸蛋白报收于80.99元，较上周的69.58元上涨16.4%。本周，近岸蛋白8月21日盘中最高价报80.99元，股价触及近一年最高点。本周关注点来自交易信息汇总：近岸蛋白因股价涨幅达15%及累计偏离值超30%多次登上龙虎榜。来自公司公告汇总：近岸蛋白股票连续三个交易日收盘价涨幅偏离值累计超30%，构成严重异常波动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789418578802,"stockEarnings":[{"period":"1week","weight":0.2474},{"period":"1month","weight":0.1038},{"period":"3month","weight":1.1719},{"period":"6month","weight":0.8109},{"period":"1year","weight":0.8139},{"period":"ytd","weight":0.9176}],"compareEarnings":[{"period":"1week","weight":-0.012},{"period":"1month","weight":-0.0107},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0038},{"period":"ytd","weight":-0.021}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"苏州近岸蛋白质科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"6364人(较上一季度减少5.49%)","perCapita":"10986股","listingDate":"2022-09-29","address":"江苏省苏州市吴江区吴江经济技术开发区云创路228号3层,4层","registeredCapital":"6991万元","survey":" 苏州近岸蛋白质科技股份有限公司的主营业务是靶点及因子类蛋白、重组抗体、酶及试剂的研发、生产、销售并提供相关技术服务。公司的主要产品是靶点及因子类蛋白、重组抗体、酶及试剂。","listedPrice":106.19},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"近岸蛋白(688137)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供近岸蛋白(688137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"近岸蛋白,688137,近岸蛋白股票,近岸蛋白股票老虎,近岸蛋白股票老虎国际,近岸蛋白行情,近岸蛋白股票行情,近岸蛋白股价,近岸蛋白股市,近岸蛋白股票价格,近岸蛋白股票交易,近岸蛋白股票购买,近岸蛋白股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"近岸蛋白(688137)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供近岸蛋白(688137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}